Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus

被引：0
|
作者：
Yanli Zeng
Qiaoduan Lin
Liang Yu
Xuelian Wang
Yiqiang Lin
Yan Zhang
Shuidi Yan
Xinxin Lu
Yijing Li
Weibin Li
Yun Xiao
机构：
[1] Xiamen University,Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine
[2] Zhongshan Hospital of Xiamen University,Ultrasonography Department
[3] Zhongshan Hospital of Xiamen University,Department of Obstetrics and Gynecology
[4] The 900Th Hospital of Joint Logistic Support Force,Institute for Laboratory Medicine
来源：
BMC Immunology | / 22卷
关键词：
CXC ligand 1 (CXCL1); Growth-related oncogene-α (GRO-α); High-avidity IgG ANAs (HA IgG ANAs); Systemic lupus erythematosus (SLE); Lupus nephritis (LN);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus
    Yip, Jonathan
    Aghdassi, Elaheh
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna D.
    Urowitz, Murray B.
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1667 - 1672
  • [22] Neutrophilia in Systemic Lupus Erythematosus As a Potential Indicator of Disease Activity
    Lewis, Emily E.
    McCune, W. Joseph
    Knight, Jason S.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Xu, Jili
    Zhang, Hongmei
    Che, Nan
    Wang, Hengjin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4779 - 4785
  • [24] FAR in systemic lupus erythematosus: a potential biomarker of disease activity and lupus nephritis
    Jili Xu
    Hongmei Zhang
    Nan Che
    Hengjin Wang
    Clinical and Experimental Medicine, 2023, 23 : 4779 - 4785
  • [25] THE RATIO OF NEUTROPHIL TO LYMPHOCYTE AS A POTENTIAL MARKER OF CLINICOPATHOLOGICAL ACTIVITY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Han, Qianqian
    Liang, Peifen
    Li, Jiajia
    Liu, Bo
    Huan'g, Rong
    Yang, Qiongqiong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [26] Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus
    Kumar, A
    Gupta, R
    Varghese, T
    Pande, RM
    Singal, VK
    Garg, OP
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1999, 110 : 190 - 193
  • [27] Immune-dysregulated neutrophils characterized by upregulation of CXCL1 may be a potential factor in the pathogenesis of abdominal aortic aneurysm and systemic lupus erythematosus
    Zhang, Lin
    Li, Que
    Zhou, Chenxing
    Zhang, Zhanman
    Zhang, Jiangfeng
    Qin, Xiao
    HELIYON, 2023, 9 (07)
  • [28] FIBRONECTIN AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Emelyanova, O.
    Trofimenko, A.
    Rusanova, O.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S196 - S196
  • [29] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus (SLE)
    Yip, Jonathan
    Aghdassi, Ellie
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna
    Urowitz, Murray
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1326 - 1326
  • [30] Semaphorin 3A-a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus
    Vadasz, Z.
    Toubi, E.
    LUPUS, 2012, 21 (12) : 1266 - 1270
12345